Prognostic factors for the efficacy of infliximab in patients with luminal fistulizing Crohn’s disease

Prognostic factors for the efficacy of infliximab in patients with luminal fistulizing Crohn’s disease

Abstract Background Enteric fistula is one of the penetrating features in Crohn’s disease (CD). This study aimed to clarify the prognostic factors for the efficacy of infliximab (IFX) treatment in luminal fistulizing CD patients. Methods We retrospectively included 26 cases diagnosed with luminal fi...

Full description

Bibliographic Details
Main Authors: Ye Ma, Runfeng Zhang, Wei Liu, Yinghao Sun, Jingnan Li, Hong Yang, Hong Lv, Yue Li, Bei Tan, Xiyu Sun, Jiaming Qian, Ji Li
Format: Article
Language:English
Published: BMC 2023-03-01
Series:BMC Gastroenterology
Subjects:
Crohn’s disease
Fistula
Infliximab
Prognostic factors
Efficacy
Online Access:https://doi.org/10.1186/s12876-023-02676-9

Internet

https://doi.org/10.1186/s12876-023-02676-9

Similar Items